BDSX - Biodesix prices upsized $35.1M stock offering

• Biodesix ( NASDAQ: BDSX ) has priced an underwritten public offering of 30.5M shares of its common stock at a price to the public of $1.15/share.
• The gross proceeds to Biodesix from the offering are expected to be $35.1M.
• Offering is expected to close on November 21, 2022.
• Underwriters are granted a 30-day option to purchase up to an additional 4,575,000 shares of its common stock at the public offering price
• All of the shares of common stock in the offering will be sold by Biodesix.

For further details see: